{"transactions":[{"id":4636440,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":32092,"kind":"person","name":"Cohen Cheryl","position":1,"cik":"0001529371","reported_name":"Cohen Cheryl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-10-06T22:05:42.000Z","date":"2026-10-02","kind":"exercise","planned":true,"acquired":false,"shares":55979,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":55979,"derivative":{"exercise_price":2.98,"exercise_date":"2023-06-12","expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":55979},"source":{"system":"sec-edgar","filing":"0001326110-26-000084","document":"wk-form4_1791324339.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1529371/000132611026000084/wk-form4_1791324339.xml","form_type":"4"}},{"id":4636439,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":32092,"kind":"person","name":"Cohen Cheryl","position":1,"cik":"0001529371","reported_name":"Cohen Cheryl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-10-06T22:05:42.000Z","date":"2026-10-02","kind":"sale","planned":true,"acquired":false,"shares":81056,"price":10.5,"value":851088.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of shares reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on February 27, 2026."}],"balance_after":100309,"source":{"system":"sec-edgar","filing":"0001326110-26-000084","document":"wk-form4_1791324339.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1529371/000132611026000084/wk-form4_1791324339.xml","form_type":"4"}},{"id":4636438,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":32092,"kind":"person","name":"Cohen Cheryl","position":1,"cik":"0001529371","reported_name":"Cohen Cheryl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-10-06T22:05:42.000Z","date":"2026-10-02","kind":"exercise","planned":true,"acquired":true,"shares":55979,"price":2.98,"value":166817.42,"ownership":{"direct":true},"balance_after":181365,"source":{"system":"sec-edgar","filing":"0001326110-26-000084","document":"wk-form4_1791324339.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1529371/000132611026000084/wk-form4_1791324339.xml","form_type":"4"}},{"id":714962,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":32092,"kind":"person","name":"Cohen Cheryl","position":1,"cik":"0001529371","reported_name":"Cohen Cheryl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-07-07T00:26:22.000Z","date":"2026-07-02","kind":"exercise","planned":true,"acquired":false,"shares":55979,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":111958,"derivative":{"exercise_price":2.98,"exercise_date":"2023-06-12","expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":55979},"source":{"system":"sec-edgar","filing":"0001529371-26-000008","document":"wk-form4_1783383979.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000152937126000008/wk-form4_1783383979.xml","form_type":"4"}},{"id":714961,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":32092,"kind":"person","name":"Cohen Cheryl","position":1,"cik":"0001529371","reported_name":"Cohen Cheryl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-07T00:26:22.000Z","date":"2026-07-02","kind":"sale","planned":true,"acquired":false,"shares":131210,"price":9.5034,"value":1246941.114,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of shares reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on February 27, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 131,210 shares sold in the price range of $9.50 to $9.52 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, ImmunityBio, Inc. (the \"Issuer\") or a security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":125386,"source":{"system":"sec-edgar","filing":"0001529371-26-000008","document":"wk-form4_1783383979.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000152937126000008/wk-form4_1783383979.xml","form_type":"4"}},{"id":714960,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":32092,"kind":"person","name":"Cohen Cheryl","position":1,"cik":"0001529371","reported_name":"Cohen Cheryl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-07T00:26:22.000Z","date":"2026-07-02","kind":"exercise","planned":true,"acquired":true,"shares":55979,"price":2.98,"value":166817.42,"ownership":{"direct":true},"balance_after":256596,"source":{"system":"sec-edgar","filing":"0001529371-26-000008","document":"wk-form4_1783383979.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000152937126000008/wk-form4_1783383979.xml","form_type":"4"}},{"id":724980,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":32092,"kind":"person","name":"Cohen Cheryl","position":1,"cik":"0001529371","reported_name":"Cohen Cheryl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2026-06-29T20:10:02.000Z","date":"2026-06-25","kind":"grant","planned":false,"acquired":true,"shares":26000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."}],"balance_after":26000,"derivative":{"exercise_price":34.09,"exercise_date":"2027-06-25","expiration_date":"2036-06-25","underlying":"Common Stock","underlying_shares":26000},"source":{"system":"sec-edgar","filing":"0001529371-26-000005","document":"form4-06292026_080658.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000152937126000005/form4-06292026_080658.xml","form_type":"4"}},{"id":742969,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":32092,"kind":"person","name":"Cohen Cheryl","position":1,"cik":"0001529371","reported_name":"Cohen Cheryl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-11T00:11:18.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":65600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the Issuer's 2025 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the shares subject to the award will vest on the earlier to occur of June 9, 2027 or the date immediately preceding the next annual meeting of stockholders."}],"balance_after":65600,"derivative":{"exercise_price":7.25,"expiration_date":"2036-06-09","underlying":"Common Stock","underlying_shares":65600},"source":{"system":"sec-edgar","filing":"0001529371-26-000003","document":"wk-form4_1781136674.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000152937126000003/wk-form4_1781136674.xml","form_type":"4"}},{"id":1104894,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":32092,"kind":"person","name":"Cohen Cheryl","position":1,"cik":"0001529371","reported_name":"Cohen Cheryl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-06-20T22:34:47.000Z","date":"2025-06-18","kind":"grant","planned":false,"acquired":true,"shares":162786,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the Issuer's 2025 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the shares subject to the award will vest on the earlier to occur of June 18, 2026 or the date immediately preceding the Issuer's next  annual meeting of stockholders."}],"balance_after":162786,"derivative":{"exercise_price":2.84,"expiration_date":"2035-06-18","underlying":"Common Stock","underlying_shares":162786},"source":{"system":"sec-edgar","filing":"0001326110-25-000093","document":"wk-form4_1750458881.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611025000093/wk-form4_1750458881.xml","form_type":"4"}},{"id":1119001,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":32092,"kind":"person","name":"Cohen Cheryl","position":1,"cik":"0001529371","reported_name":"Cohen Cheryl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2025-06-09T20:06:11.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":16500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."}],"balance_after":16500,"derivative":{"exercise_price":19.53,"exercise_date":"2026-06-05","expiration_date":"2035-06-05","underlying":"Common Stock","underlying_shares":16500},"source":{"system":"sec-edgar","filing":"0001415889-25-016215","document":"form4-06092025_080601.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588925016215/form4-06092025_080601.xml","form_type":"4"}},{"id":1478173,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":32092,"kind":"person","name":"Cohen Cheryl","position":1,"cik":"0001529371","reported_name":"Cohen Cheryl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2024-06-17T20:10:24.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":16500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."}],"balance_after":16500,"derivative":{"exercise_price":36.43,"exercise_date":"2025-06-13","expiration_date":"2034-06-13","underlying":"Common Stock","underlying_shares":16500},"source":{"system":"sec-edgar","filing":"0001415889-24-017153","document":"form4-06172024_080620.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588924017153/form4-06172024_080620.xml","form_type":"4"}},{"id":1480431,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":32092,"kind":"person","name":"Cohen Cheryl","position":1,"cik":"0001529371","reported_name":"Cohen Cheryl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-13T22:49:40.000Z","date":"2024-06-11","kind":"grant","planned":false,"acquired":true,"shares":77633,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the Issuer's 2015 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the shares subject to the award will vest on the earlier to occur of June 11, 2025 or the date immediately preceding the next annual meeting of stockholders."}],"balance_after":77633,"derivative":{"exercise_price":5.96,"expiration_date":"2034-06-11","underlying":"Common Stock","underlying_shares":77633},"source":{"system":"sec-edgar","filing":"0001326110-24-000079","document":"wk-form4_1718318972.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611024000079/wk-form4_1718318972.xml","form_type":"4"}},{"id":1850840,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":32092,"kind":"person","name":"Cohen Cheryl","position":1,"cik":"0001529371","reported_name":"Cohen Cheryl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2023-06-20T20:07:49.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":11300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."}],"balance_after":11300,"derivative":{"exercise_price":36.87,"exercise_date":"2024-06-15","expiration_date":"2033-06-15","underlying":"Common Stock","underlying_shares":11300},"source":{"system":"sec-edgar","filing":"0001415889-23-010033","document":"form4-06202023_080641.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000141588923010033/form4-06202023_080641.xml","form_type":"4"}},{"id":1854136,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":32092,"kind":"person","name":"Cohen Cheryl","position":1,"cik":"0001529371","reported_name":"Cohen Cheryl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-15T22:28:08.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":158263,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the 2015 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the shares subject to the award will vest on the earlier to occur of June 13, 2024 or the date immediately preceding the next annual meeting of stockholders."}],"balance_after":158263,"derivative":{"exercise_price":2.99,"expiration_date":"2033-06-13","underlying":"Common Stock","underlying_shares":158263},"source":{"system":"sec-edgar","filing":"0001326110-23-000088","document":"wk-form4_1686868079.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611023000088/wk-form4_1686868079.xml","form_type":"4"}},{"id":2210651,"issuer":{"id":7396,"kind":"organization","name":"Lite Strategy, Inc."},"owners":[{"id":32092,"kind":"person","name":"Cohen Cheryl","position":1,"cik":"0001529371","reported_name":"Cohen Cheryl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-07-07T20:25:46.000Z","date":"2022-07-05","kind":"grant","acquired":true,"shares":87500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest in equal monthly installments over twelve months."}],"balance_after":87500,"derivative":{"exercise_price":0.54,"expiration_date":"2032-07-05","underlying":"Common Stock","underlying_shares":87500},"source":{"system":"sec-edgar","filing":"0000899243-22-025709","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1262104/000089924322025709/doc4.xml","form_type":"4"}},{"id":2229171,"issuer":{"id":4208,"kind":"organization","name":"Celldex Therapeutics, Inc."},"owners":[{"id":32092,"kind":"person","name":"Cohen Cheryl","position":1,"cik":"0001529371","reported_name":"Cohen Cheryl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-06-17T20:05:44.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":27200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"date","element":"transactionDate","label":"F1","text":"Represents option granted by the Issuer pursuant to its 2021 Omnibus Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One third vests on the first, second and third anniversaries of the date of grant."}],"balance_after":27200,"derivative":{"exercise_price":22.48,"expiration_date":"2032-06-16","underlying":"Common Stock","underlying_shares":27200},"source":{"system":"sec-edgar","filing":"0001493152-22-017153","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/744218/000149315222017153/ownership.xml","form_type":"4"}},{"id":2231332,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":32092,"kind":"person","name":"Cohen Cheryl","position":1,"cik":"0001529371","reported_name":"Cohen Cheryl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-16T01:22:20.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":167937,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the 2015 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the shares subject to the award will vest on the earlier to occur of June 14, 2023 or the date immediately preceding the 2023 annual meeting of stockholders."}],"balance_after":167937,"derivative":{"exercise_price":2.98,"expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":167937},"source":{"system":"sec-edgar","filing":"0001326110-22-000050","document":"wf-form4_165534252497788.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000132611022000050/wf-form4_165534252497788.xml","form_type":"4"}},{"id":2592119,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":32092,"kind":"person","name":"Cohen Cheryl","position":1,"cik":"0001529371","reported_name":"Cohen Cheryl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-24T22:07:10.000Z","date":"2021-08-23","kind":"sale","acquired":false,"shares":14801,"price":10.1206,"value":149795.0006,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of shares reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on May 13, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average share price of an aggregate total of 14,801 shares sold in the price range of $10.02 to $10.27 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":200617,"source":{"system":"sec-edgar","filing":"0001209191-21-053210","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000120919121053210/doc4.xml","form_type":"4"}},{"id":2592118,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":32092,"kind":"person","name":"Cohen Cheryl","position":1,"cik":"0001529371","reported_name":"Cohen Cheryl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-24T22:07:10.000Z","date":"2021-08-20","kind":"sale","acquired":false,"shares":9976,"price":10.0048,"value":99807.8848,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of shares reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on May 13, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 9,976 shares sold in the price range of $10.00 to $10.02 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":215418,"source":{"system":"sec-edgar","filing":"0001209191-21-053210","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000120919121053210/doc4.xml","form_type":"4"}},{"id":2596115,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":32092,"kind":"person","name":"Cohen Cheryl","position":1,"cik":"0001529371","reported_name":"Cohen Cheryl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-20T00:42:47.000Z","date":"2021-08-18","kind":"sale","acquired":false,"shares":2133,"price":10.0277,"value":21389.0841,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of shares reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on May 13, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the weighted average share price of an aggregate total of 2,133 shares sold in the price range of $10.00 to $10.05 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":225394,"source":{"system":"sec-edgar","filing":"0001209191-21-052660","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000120919121052660/doc4.xml","form_type":"4"}},{"id":2596114,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":32092,"kind":"person","name":"Cohen Cheryl","position":1,"cik":"0001529371","reported_name":"Cohen Cheryl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-20T00:42:47.000Z","date":"2021-08-17","kind":"sale","acquired":false,"shares":43398,"price":10.124,"value":439361.352,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale of shares reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on May 13, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 43,398 shares sold in the price range of $10.00 to $10.61 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":227527,"source":{"system":"sec-edgar","filing":"0001209191-21-052660","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000120919121052660/doc4.xml","form_type":"4"}},{"id":2640857,"issuer":{"id":7396,"kind":"organization","name":"Lite Strategy, Inc."},"owners":[{"id":32092,"kind":"person","name":"Cohen Cheryl","position":1,"cik":"0001529371","reported_name":"Cohen Cheryl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-06T22:56:52.000Z","date":"2021-07-01","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest in equal monthly installments over twelve months."}],"balance_after":50000,"derivative":{"exercise_price":2.95,"expiration_date":"2031-07-01","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-21-045653","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1262104/000120919121045653/doc4.xml","form_type":"4"}},{"id":2644322,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":32092,"kind":"person","name":"Cohen Cheryl","position":1,"cik":"0001529371","reported_name":"Cohen Cheryl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-02T21:34:09.000Z","date":"2021-06-30","kind":"grant","acquired":true,"shares":8140,"price":1.52,"value":12372.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents common stock equity awards issued under the Issuer's 2017 Stock Option and Incentive Plan to the non-employee directors of the Issuer in lieu of cash retainer fees pursuant to its non-employee director compensation policy. The price per share was based on the average closing price of the Company's common stock over the quarter ended June 30, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents common stock equity awards issued under the Issuer's 2017 Stock Option and Incentive Plan to the non-employee directors of the Issuer in lieu of cash retainer fees pursuant to its non-employee director compensation policy. The price per share was based on the average closing price of the Company's common stock over the quarter ended June 30, 2021."}],"balance_after":16160,"source":{"system":"sec-edgar","filing":"0000899243-21-027281","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000089924321027281/doc4.xml","form_type":"4"}},{"id":2658668,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":32092,"kind":"person","name":"Cohen Cheryl","position":1,"cik":"0001529371","reported_name":"Cohen Cheryl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-22T21:42:03.000Z","date":"2021-06-17","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option is fully vested."}],"balance_after":100000,"derivative":{"exercise_price":1.87,"expiration_date":"2031-06-17","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000899243-21-025336","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000089924321025336/doc4.xml","form_type":"4"}},{"id":2669967,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":32092,"kind":"person","name":"Cohen Cheryl","position":1,"cik":"0001529371","reported_name":"Cohen Cheryl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-14T22:34:20.000Z","date":"2021-06-10","kind":"grant","acquired":true,"shares":26064,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the 2015 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the shares subject to the award will vest on the earlier to occur of June 10, 2022 or the date immediately preceding the 2022 annual meeting of stockholders."}],"balance_after":26064,"derivative":{"exercise_price":14.91,"expiration_date":"2031-06-10","underlying":"Common Stock","underlying_shares":26064},"source":{"system":"sec-edgar","filing":"0001209191-21-040349","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000120919121040349/doc4.xml","form_type":"4"}},{"id":2760996,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":32092,"kind":"person","name":"Cohen Cheryl","position":1,"cik":"0001529371","reported_name":"Cohen Cheryl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-03T00:30:34.000Z","date":"2021-03-31","kind":"grant","acquired":true,"shares":8020,"price":1.543,"value":12374.86,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents common stock equity awards issued under the Issuer's 2017 Stock Option and Incentive Plan to the non-employee directors of the Issuer in lieu of cash retainer fees pursuant to its non-employee director compensation policy. The price per share was based on the average closing price of the Company's common stock over the quarter ended March 31, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents common stock equity awards issued under the Issuer's 2017 Stock Option and Incentive Plan to the non-employee directors of the Issuer in lieu of cash retainer fees pursuant to its non-employee director compensation policy. The price per share was based on the average closing price of the Company's common stock over the quarter ended March 31, 2021."}],"balance_after":8020,"source":{"system":"sec-edgar","filing":"0000899243-21-014676","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000089924321014676/doc4.xml","form_type":"4"}},{"id":2881467,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":32092,"kind":"person","name":"Cohen Cheryl","position":1,"cik":"0001529371","reported_name":"Cohen Cheryl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-04T02:35:39.000Z","date":"2021-02-01","kind":"grant","acquired":true,"shares":17857,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options shall vest in four equal quarterly installments beginning on February 1, 2021."}],"balance_after":17857,"derivative":{"exercise_price":1.46,"expiration_date":"2031-02-01","underlying":"Common Stock","underlying_shares":17857},"source":{"system":"sec-edgar","filing":"0000899243-21-004893","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000089924321004893/doc4.xml","form_type":"4"}},{"id":3058546,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":32092,"kind":"person","name":"Cohen Cheryl","position":1,"cik":"0001529371","reported_name":"Cohen Cheryl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-13T23:10:38.000Z","date":"2020-08-11","kind":"sale","acquired":false,"shares":30000,"price":9.9595,"value":298785.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sales made in order to satisfy tax payments paid, accrued and/or owed by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average share price of an aggregate total of 30,000 shares sold in the price range of $9.91 to $9.99 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":270925,"source":{"system":"sec-edgar","filing":"0001209191-20-046675","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000120919120046675/doc4.xml","form_type":"4"}},{"id":3087329,"issuer":{"id":7396,"kind":"organization","name":"Lite Strategy, Inc."},"owners":[{"id":32092,"kind":"person","name":"Cohen Cheryl","position":1,"cik":"0001529371","reported_name":"Cohen Cheryl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-07T16:30:54.000Z","date":"2020-07-02","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options will vest in equal monthly installments over twelve months."}],"balance_after":50000,"derivative":{"exercise_price":3.49,"expiration_date":"2030-07-02","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000899243-20-018597","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1262104/000089924320018597/doc4.xml","form_type":"4"}},{"id":3098409,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":32092,"kind":"person","name":"Cohen Cheryl","position":1,"cik":"0001529371","reported_name":"Cohen Cheryl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-26T20:40:25.000Z","date":"2020-06-24","kind":"grant","acquired":true,"shares":52144,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options shall vest annually on the earlier of the one year anniversary of the Grant Date or the Company's next annual meeting, subject to director's continued service on the Board at such time."}],"balance_after":52144,"derivative":{"exercise_price":1.22,"expiration_date":"2030-06-24","underlying":"Common Stock","underlying_shares":52144},"source":{"system":"sec-edgar","filing":"0000899243-20-017769","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000089924320017769/doc4.xml","form_type":"4"}},{"id":3113217,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":32092,"kind":"person","name":"Cohen Cheryl","position":1,"cik":"0001529371","reported_name":"Cohen Cheryl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-11T22:20:52.000Z","date":"2020-06-10","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the 2015 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the shares subject to the award will vest on the earlier to occur of June 10, 2021 or the date immediately preceding the 2021 annual meeting of stockholders."}],"balance_after":100000,"derivative":{"exercise_price":6.21,"expiration_date":"2030-06-10","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-20-036032","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000120919120036032/doc4.xml","form_type":"4"}},{"id":3177125,"issuer":{"id":7396,"kind":"organization","name":"Lite Strategy, Inc."},"owners":[{"id":32092,"kind":"person","name":"Cohen Cheryl","position":1,"cik":"0001529371","reported_name":"Cohen Cheryl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-04-14T21:17:04.000Z","date":"2020-04-10","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"20,000 options will vest in equal monthly installments over thirty-six months from April 10, 2020 and 10,000 options shall vest in equal monthly installments over twelve months from April 10, 2020."}],"balance_after":30000,"derivative":{"exercise_price":1.71,"expiration_date":"2030-04-10","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000899243-20-010723","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1262104/000089924320010723/doc4.xml","form_type":"4"}},{"id":3461906,"issuer":{"id":6160,"kind":"organization","name":"Eledon Pharmaceuticals, Inc."},"owners":[{"id":32092,"kind":"person","name":"Cohen Cheryl","position":1,"cik":"0001529371","reported_name":"Cohen Cheryl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-07-15T20:05:19.000Z","date":"2019-07-11","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":20000,"derivative":{"exercise_price":0.88,"exercise_date":"2020-07-11","expiration_date":"2029-07-11","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000899243-19-019597","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404281/000089924319019597/doc4.xml","form_type":"4"}},{"id":3484024,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":32092,"kind":"person","name":"Cohen Cheryl","position":1,"cik":"0001529371","reported_name":"Cohen Cheryl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-19T21:25:21.000Z","date":"2019-06-18","kind":"grant","acquired":true,"shares":21400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options shall vest annually on the earlier of the one year anniversary of the Grant Date or the Company's next annual meeting, subject to director's continued service on the Board at such time."}],"balance_after":21400,"derivative":{"exercise_price":0.96,"expiration_date":"2029-06-18","underlying":"Common Stock","underlying_shares":21400},"source":{"system":"sec-edgar","filing":"0000899243-19-017438","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000089924319017438/doc4.xml","form_type":"4"}},{"id":3496974,"issuer":{"id":3618,"kind":"organization","name":"ImmunityBio, Inc.","symbol":"IBRX"},"owners":[{"id":32092,"kind":"person","name":"Cohen Cheryl","position":1,"cik":"0001529371","reported_name":"Cohen Cheryl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-07T20:38:57.000Z","date":"2019-06-06","kind":"grant","acquired":true,"shares":300925,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of NantKwest, Inc. common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the 2015 Equity Incentive Plan) 1/3 of the RSUs shall vest annually  beginning on June 6, 2020"}],"balance_after":300925,"source":{"system":"sec-edgar","filing":"0001209191-19-035573","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1326110/000120919119035573/doc4.xml","form_type":"4"}},{"id":3815339,"issuer":{"id":6306,"kind":"organization","name":"IMMUNIC, INC."},"owners":[{"id":32092,"kind":"person","name":"Cohen Cheryl","position":1,"cik":"0001529371","reported_name":"Cohen Cheryl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-09-14T20:08:57.000Z","date":"2018-09-12","kind":"sale","acquired":false,"shares":3500,"price":0.55,"value":1925.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares held by Cheryl L. Cohen Trust U/A 04/01/05 Cheryl L. Cohen Trustee."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001280776-18-000085","document":"wf-form4_153695571919596.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280776/000128077618000085/wf-form4_153695571919596.xml","form_type":"4"}},{"id":3884938,"issuer":{"id":6074,"kind":"organization","name":"Whitehawk Therapeutics, Inc.","symbol":"WHWK"},"owners":[{"id":32092,"kind":"person","name":"Cohen Cheryl","position":1,"cik":"0001529371","reported_name":"Cohen Cheryl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-22T21:54:21.000Z","date":"2018-06-20","kind":"grant","acquired":true,"shares":42800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options shall vest annually over three years from the Grant Date, subject to director's continued service on the Board at such time."}],"balance_after":42800,"derivative":{"exercise_price":4,"expiration_date":"2028-06-20","underlying":"Common Stock","underlying_shares":42800},"source":{"system":"sec-edgar","filing":"0000899243-18-017743","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1422142/000089924318017743/doc4.xml","form_type":"4"}},{"id":3893668,"issuer":{"id":6160,"kind":"organization","name":"Eledon Pharmaceuticals, Inc."},"owners":[{"id":32092,"kind":"person","name":"Cohen Cheryl","position":1,"cik":"0001529371","reported_name":"Cohen Cheryl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-14T21:54:49.000Z","date":"2018-06-13","kind":"grant","acquired":true,"shares":9100,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":9100,"derivative":{"exercise_price":6.18,"exercise_date":"2019-06-13","expiration_date":"2028-06-13","underlying":"Common Stock","underlying_shares":9100},"source":{"system":"sec-edgar","filing":"0000899243-18-016655","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404281/000089924318016655/doc4.xml","form_type":"4"}},{"id":3916878,"issuer":{"id":6306,"kind":"organization","name":"IMMUNIC, INC."},"owners":[{"id":32092,"kind":"person","name":"Cohen Cheryl","position":1,"cik":"0001529371","reported_name":"Cohen Cheryl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-05-25T20:09:22.000Z","date":"2018-05-23","kind":"grant","acquired":true,"shares":29538,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the 2014 Equity Incentive Plan) through the vesting date, 100% of the shares will vest upon the earlier of the one (1) year anniversary of the Grant Date or the day prior to the Company's 2019 annual meeting of stockholders."}],"balance_after":29538,"derivative":{"exercise_price":6.1,"expiration_date":"2028-05-22","underlying":"Common Stock","underlying_shares":29538},"source":{"system":"sec-edgar","filing":"0001280776-18-000043","document":"wf-form4_152727894752915.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280776/000128077618000043/wf-form4_152727894752915.xml","form_type":"4"}},{"id":4263982,"issuer":{"id":6160,"kind":"organization","name":"Eledon Pharmaceuticals, Inc."},"owners":[{"id":32092,"kind":"person","name":"Cohen Cheryl","position":1,"cik":"0001529371","reported_name":"Cohen Cheryl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-07-05T20:05:40.000Z","date":"2017-06-30","kind":"grant","acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 18,000 shares of the Issuer's Common Stock. The shares will vest ratably each quarter over three years beginning on June 30, 2017."}],"balance_after":18000,"derivative":{"exercise_price":5.85,"expiration_date":"2027-06-30","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0000899243-17-017762","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404281/000089924317017762/doc4.xml","form_type":"4"}},{"id":4304524,"issuer":{"id":6306,"kind":"organization","name":"IMMUNIC, INC."},"owners":[{"id":32092,"kind":"person","name":"Cohen Cheryl","position":1,"cik":"0001529371","reported_name":"Cohen Cheryl","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-05-25T21:27:20.000Z","date":"2017-05-23","kind":"grant","acquired":true,"shares":45022,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Subject to the reporting person's continuing to be a Service Provider (as defined in the 2014 Equity Incentive Plan) through the vesting date, 100% of the shares will vest upon the earlier of the one (1) year anniversary from May 23, 2017 or the day prior to the Company's 2018 annual meeting of stockholders."}],"balance_after":45022,"derivative":{"exercise_price":3.2,"expiration_date":"2027-05-22","underlying":"Common Stock","underlying_shares":45022},"source":{"system":"sec-edgar","filing":"0001280776-17-000044","document":"wf-form4_149574762511530.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1280776/000128077617000044/wf-form4_149574762511530.xml","form_type":"4"}}]}